Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy. - Wikidata - wikimedia - TriplyDB

Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy.

Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy.

http://www.wikidata.org/entity/Q34175757

about

Choice of Cell Source in Cell-Based Therapies for Retinal Damage due to Age-Related Macular Degeneration: A Review hiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicine Concise Review: Patient-Specific Stem Cells to Interrogate Inherited Eye Disease Pluripotent stem cells and gene therapy Molecular therapeutics for heritable skin diseases Hematopoietic stem cell engineering at a crossroads Human pluripotent stem cells for modelling human liver diseases and cell therapy Using human induced pluripotent stem cells to treat retinal disease Targeted Gene Correction in Osteopetrotic-Induced Pluripotent Stem Cells for the Generation of Functional Osteoclasts Genome sequencing of mouse induced pluripotent stem cells reveals retroelement stability and infrequent DNA rearrangement during reprogramming.Photoreceptor Outer Segment-like Structures in Long-Term 3D Retinas from Human Pluripotent Stem Cells Characterization of spermatogonial stem cells lacking intercellular bridges and genetic replacement of a mutation in spermatogonial stem cells.Recapitulating and Correcting Marfan Syndrome in a Cellular Model.Low incidence of off-target mutations in individual CRISPR-Cas9 and TALEN targeted human stem cell clones detected by whole-genome sequencing.An effective approach to prevent immune rejection of human ESC-derived allografts.Selection-independent generation of gene knockout mouse embryonic stem cells using zinc-finger nucleases.Induced pluripotent stem cells--opportunities for disease modelling and drug discovery.Implications and limitations of cellular reprogramming for psychiatric drug development.Loss of MITF expression during human embryonic stem cell differentiation disrupts retinal pigment epithelium development and optic vesicle cell proliferation.Induced Pluripotent Stem Cells Meet Genome Editing Few single nucleotide variations in exomes of human cord blood induced pluripotent stem cells.Direct cloning of isogenic murine DNA in yeast and relevance of isogenicity for targeting in embryonic stem cells.Generation of 3D skin equivalents fully reconstituted from human induced pluripotent stem cells (iPSCs).Intermediate filament protein accumulation in motor neurons derived from giant axonal neuropathy iPSCs rescued by restoration of gigaxonin Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease.Human vascular tissue models formed from human induced pluripotent stem cell derived endothelial cells.Proteomics and pluripotency iPS Cells for Modelling and Treatment of Retinal Diseases In situ genetic correction of the sickle cell anemia mutation in human induced pluripotent stem cells using engineered zinc finger nucleases.Reprogrammed keratinocytes from elderly type 2 diabetes patients suppress senescence genes to acquire induced pluripotency.Transcriptional analysis of pluripotency reveals the Hippo pathway as a barrier to reprogramming.Focus on Kir7.1: physiology and channelopathy Optic vesicle-like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment.A scalable approach to prevent teratoma formation of human embryonic stem cells Targeted gene correction of laminopathy-associated LMNA mutations in patient-specific iPSCs New lessons learned from disease modeling with induced pluripotent stem cells.Simultaneous Reprogramming and Gene Correction of Patient Fibroblasts.Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells.Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells.Modeling the blood-brain barrier using stem cell sources.

P2860

Q21284849-11E63A6B-3D36-4A67-82F8-E4D886519147 Q26751506-934C7855-6C9F-4047-A468-7699E3DEE900 Q26774786-A4A20B4A-B401-4BF1-8B75-0E2B964DA367 Q26827643-022750D5-AC84-4CB3-A5A9-B7AF438E4877 Q26865551-BE62166D-B446-4E4F-B336-1836A238021C Q27001570-7480B736-1ABE-422C-9889-3683944CFD39 Q27005360-31D79292-2205-4990-A303-327842525D5A Q27015087-7B2D65CA-D3A4-40D0-A4CA-626519AE7F3E Q30398603-0A2225FA-BB02-44F6-9811-8AB486B955E7 Q30413933-DF0295BF-34CB-416C-AF8F-D9754481E195 Q30850205-EAF82763-7B7D-451D-AF57-F476446C1893 Q31068431-C15A4C17-C2A0-406E-9DF2-8495E53B0825 Q33717760-AD85F1CB-4913-42EE-8474-F7AE0740FFEE Q33849553-171D0A47-C244-490E-BDC7-E5EA157DEEFC Q34039500-A5936758-4458-40E4-9639-1C9867A4EBB1 Q34110518-A5799822-218B-4E9C-84A2-458FB4C8EE23 Q34231818-5648D2BE-355A-4D59-8374-73B280A08E9B Q34385134-0844D22A-863B-4ACE-B50C-E4F2A05A1EE1 Q34463231-9BF6BB2D-2D6D-4650-9110-B45756CA6EC1 Q34525438-BFDBE94C-2AC8-4962-B369-9BD8D8828FC7 Q34661781-01E5F729-F058-4EF5-B917-2FA6D9E71D05 Q34994552-65F58271-875F-450E-AE19-E8AA70BAE07B Q35023324-494FBABC-D9E9-44C2-84C7-BE88DF20557D Q35473596-1756AF15-01BA-43CE-9DBD-DBB654822F83 Q35525329-136B6D3C-FB71-4A10-A2E9-881CC572F7F0 Q35542968-DF85FAD8-65D7-44A6-B32F-0A85CBB987AA Q35570890-D55E22EF-EFF5-45E0-B02C-B619A469FA6C Q35750572-0E3E1448-7BBC-4EFF-8969-7179CDD96357 Q35775664-F4FF3B98-94F0-4F56-853D-FFA95DED9FB6 Q35799834-49E872FD-331D-48B4-941C-E2BF6F9C061A Q35860353-63629CD9-8F6A-4B36-A63F-314836FDFBD9 Q36125019-116E0E19-2797-4ACC-BB5B-D67FD96E1EDA Q36143248-86DFC5AE-20D0-489B-BBAA-3A5B4B81BB8B Q36294776-6CEEA0DC-2DB1-46C8-8A3F-B5CB42BA93F9 Q36345932-089247BC-B100-41CA-87B1-E8A6473E24D2 Q36374130-AC8023AB-27AE-4D18-9D4B-40DCC943B028 Q36379464-928E7BC0-73B5-40B3-80CA-2C45D8ADAF84 Q36493686-66BC6169-9360-48F8-99DF-5C8C3B8229A2 Q36512584-C6F010BE-F7F8-44C9-BE63-8A6820A1C7B6 Q36588683-71D59D3B-F89E-41B0-AE50-71C4BC7B25D1

P2860

Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy.

http://www.wikidata.org/entity/Q34175757

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Genetic correction and analysi ...... a patient with gyrate atrophy.

@ast

Genetic correction and analysi ...... a patient with gyrate atrophy.

@en

Genetic correction and analysi ...... a patient with gyrate atrophy.

@nl

type

label

Genetic correction and analysi ...... a patient with gyrate atrophy.

@ast

Genetic correction and analysi ...... a patient with gyrate atrophy.

@en

Genetic correction and analysi ...... a patient with gyrate atrophy.

@nl

prefLabel

Genetic correction and analysi ...... a patient with gyrate atrophy.

@ast

Genetic correction and analysi ...... a patient with gyrate atrophy.

@en

Genetic correction and analysi ...... a patient with gyrate atrophy.

@nl

P1433

Q34175757-95CEC6C2-609F-458F-9DA7-1FC2B06ADA04

P1476

Q34175757-7B68C527-27E0-4AFF-A921-29E669D64693

P2093

Q34175757-04E2286D-2EA0-4E75-B6DD-F633E25A035A

Q34175757-0F5CC489-1F1A-4BE4-BEC0-54F169382A7B

Q34175757-115F225E-2C43-45AF-9321-D6E09E4A554E

Q34175757-1A2ECBA8-D525-489B-A3FF-F500084D5492

Q34175757-2B3097F0-5445-493E-A837-AE710A34BBDD

Q34175757-3A795B2E-5FF1-4EFF-B18C-0FCF083C1228

Q34175757-4F0C4B87-B8AB-4084-8AA9-ADBFA22F52B0

Q34175757-7836DB5D-0FCE-4AEC-8BF8-DC170B8C219E

Q34175757-83791F02-E1EF-4C84-AA90-09D551566338

Q34175757-87D82657-BDDA-4F4B-B086-BA31239DB683

P2860

Q34175757-23609BCD-6599-4216-98B6-B85F163DC866

Q34175757-2E3125F6-0FC1-44CC-9B50-6C8BD3187DB4

Q34175757-3BF2FB08-3BC8-44EE-B415-0A9D6784B436

Q34175757-42186A18-2515-4FB5-B2E1-60FB38202FFB

Q34175757-45A08970-A6E3-4860-AAF7-B2C963B2D303

Q34175757-4D565260-AE4E-4A3E-BE51-7D3296AA5064

Q34175757-4DA2CBE9-AFA1-4766-BBE1-377D59867BFC

Q34175757-50437940-C529-4A7B-A44B-D99DC41F2D70

Q34175757-64CC3B0B-AB63-4C27-B2B0-26B5B9F8980E

Q34175757-66BF905D-6C37-4D67-A036-36214E2B43C1

P304

Q34175757-DE587D45-7C91-41E7-88D2-AE1CF30DFC4B

P31

Q34175757-F89E5881-93A9-43BD-8390-93656E1ED9B8

P356

Q34175757-425BAD23-AE04-4FFB-8DAC-5B0446A36BBA

P407

Q34175757-FE1240B3-03DC-4179-8466-A0CB964D99C4

P433

Q34175757-5724C70E-9D1C-4642-B8DA-0FAF4DFEF9C1

P478

Q34175757-8A568B7C-D955-4AA0-A812-05A3327A3F19

P50

Q34175757-D1B5EB5C-02CA-4B9E-A161-38D95125A093

P577

Q34175757-95EC075C-7A27-456F-B97F-8B1B63C2B355

P5875

Q34175757-0D77A6F9-86D5-42F8-A413-60439272DAE1

P698

Q34175757-090DD1AA-872A-4E33-83FB-4023C45E15B7

P921

Q34175757-3C4DB731-8E64-4A89-9D32-DCC911DCF4CC

P932

Q34175757-C5CB00D4-2BA2-4E58-AC2E-F7EAED4562C5

P356

PNAS.1103388108

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Genetic correction and analysi ...... a patient with gyrate atrophy

@en

P2093

Athurva Gore

http://www.w3.org/2001/XMLSchema#string

Benjamin S Nisler

http://www.w3.org/2001/XMLSchema#string

Brian E McIntosh

http://www.w3.org/2001/XMLSchema#string

Daniel R Gulbranson

http://www.w3.org/2001/XMLSchema#string

David M Gamm

http://www.w3.org/2001/XMLSchema#string

David T Vereide

http://www.w3.org/2001/XMLSchema#string

Goukai Chen

http://www.w3.org/2001/XMLSchema#string

Ho-Lim Fung

http://www.w3.org/2001/XMLSchema#string

James A Thomson

http://www.w3.org/2001/XMLSchema#string

Jeff Nie

http://www.w3.org/2001/XMLSchema#string

P2860

Induced pluripotent stem cell lines derived from human somatic cells

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

Human induced pluripotent stem cells free of vector and transgene sequences

Somatic coding mutations in human induced pluripotent stem cells

Generation of induced pluripotent stem cells using recombinant proteins

piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells

Actin-myosin contractility is responsible for the reduced viability of dissociated human embryonic stem cells.

Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat

P304

6537-6542

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1103388108

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50999585

http://www.w3.org/2001/XMLSchema#string

P698

21464322

http://www.w3.org/2001/XMLSchema#string

P921

P932

3080993

http://www.w3.org/2001/XMLSchema#string